Emerging News and Research in Prostate Cancer Imaging — July 2024

News
Slideshow

Catch up on the most-well viewed prostate cancer imaging content in July 2024.

Touching on a variety of topics, ranging from locoregional staging and mpMRI-targeted biopsies to an emerging PSMA agent for metastatic castration-resistant prostate cancer (mCRPC), here are the top five most well-viewed prostate cancer imaging content for July 2024.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Nina Kottler, MD, MS
Brian F. Chapin, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.